Skip to main content
PMC home page
Sarcoma logoLink to Sarcoma
. 1999 Mar;3(1):11–15. doi: 10.1080/13577149977811

Ewing's Sarcoma of the Head and Neck: A Retrospective Analysis of 24 Cases

Ayman Allam 1, Gamal El-Husseiny 1, Yasser Khafaga 1, Alaa Kandil 1, Alan Gray 1, Adnan Ezzat 2, Henrik Schultz 1,✉
PMCID: PMC2395405  PMID: 18521259

Abstract

Introduction and purpose. Primary Ewing's sarcoma arising from the bones of the head and neck region is extremely rare representing only 1– 4% of all Ewing's sarcoma cases. Previous reports suggest a better prognosis for that particular anatomic site. The purpose of this study was to analyze the clinico-epidemiologic characteristics of that rare clinical presentation, as well as its patterns of failure and prognosis following treatment.

Materials and methods. This study included a retrospective review of the medical records of patients with the diagnosis of Ewing's sarcoma of the head and neck region treated at King Faisal Specialist Hospital and Research Center between 1975 and 1996.

Results. Out of a total number of 24 cases analyzed, there were 17 males and 7 females with a ratio of 2.4:1. The median age at diagnosis was 16.5 years. A painful swelling was the most common clinical presentation.The maxilla was the most common site of presentation (9/24 cases). There were 3/24 cases who presented with metastatic disease at diagnosis.The majority of patients (16/24 cases) had a tumor size >10 cm. Most patients were treated with systemic chemotherapy plus localized irradiation following an initial biopsy.With a mean follow up of 3.4 years, the 5-year actual overall survival (OS) for the whole group was 53%, while the 5-year actuarial disease-free survival (DFS) was 30%. These figures were higher than those repor ted from our institution for young patients (≤ 14 years treated for Ewing' s sarcoma in other anatomic locations (30% v 15%). The response to chemotherapy was the only prognostic factor that affected both the OS and DFS.

Conclusion. The prognosis of Ewing's sarcoma of the head and neck region is slightly better than that of other anatomic sites.The response to systemic chemotherapy is one of the most important prognostic factors affecting both DFS and OS of Ewing's sarcoma of the head and neck. Multimodality therapy consisting of an initial biopsy, aggressive combination chemotherapy and localized radiotherapy is the treatment of choice for Ewing's sarcoma of the head and neck region and may result in long-term survival.

Full Text

The Full Text of this article is available as a PDF (114.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez-Berdecia A., Schut L., Bruce D. A. Localized primary intracranial Ewing's sarcoma of the orbital roof. Case report. J Neurosurg. 1979 Jun;50(6):811–813. doi: 10.3171/jns.1979.50.6.0811. [DOI] [PubMed] [Google Scholar]
  2. Burnet N. G., Bliss J. M., Harmer C. L. The Impact of Radiotherapy Dose on Local Control of Ewing's Sarcoma of Bone. Sarcoma. 1997;1(1):31–38. doi: 10.1080/13577149778452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DAHLIN D. C., COVENTRY M. B., SCANLON P. W. Ewing's sarcoma. A critical analysis of 165 cases. J Bone Joint Surg Am. 1961 Mar;43-A:185–192. [PubMed] [Google Scholar]
  4. Falk S., Alpert M. Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet. 1967 Feb;124(2):319–324. [PubMed] [Google Scholar]
  5. Fiorillo A., Tranfa F., Canale G., Fariello I., D'Amore R., De Chiara C., Vassallo P., Muto P., De Rosa G., Bonavolonta G. Primary Ewing's sarcoma of the maxilla, a rare and curable localization: report of two new cases, successfully treated by radiotherapy and systemic chemotherapy. Cancer Lett. 1996 Jun 5;103(2):177–182. doi: 10.1016/0304-3835(96)04210-3. [DOI] [PubMed] [Google Scholar]
  6. Hadfield M. G., Luo V. Y., Williams R. L., Ward J. D., Russo C. P. Ewing's sarcoma of the skull in an infant. A case report and review. Pediatr Neurosurg. 1996 Aug;25(2):100–104. doi: 10.1159/000121104. [DOI] [PubMed] [Google Scholar]
  7. Mishra H. B., Haran R. P., Joseph T., Chandi S. M. Primary Ewing's sarcoma of the skull. A report of two cases. Br J Neurosurg. 1993;7(6):683–686. doi: 10.3109/02688699308995099. [DOI] [PubMed] [Google Scholar]
  8. O'Connell J. E., Calder C., Raafat F., Proops D. Ewing's sarcoma of the retropharynx. J Laryngol Otol. 1994 Apr;108(4):363–366. doi: 10.1017/s0022215100126799. [DOI] [PubMed] [Google Scholar]
  9. Posnick J. C., Louie G., Zuker R., Weitzman S. Ewing's sarcoma: primary involvement of the zygoma undergoing resection and immediate reconstruction. Plast Reconstr Surg. 1992 May;89(5):956–961. [PubMed] [Google Scholar]
  10. Razek A., Perez C. A., Tefft M., Nesbit M., Vietti T., Burgert E. O., Jr, Kissane J., Pritchard D. J., Gehan E. A. Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma. Cancer. 1980 Aug 1;46(3):516–521. doi: 10.1002/1097-0142(19800801)46:3<516::aid-cncr2820460316>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  11. Siegal G. P., Oliver W. R., Reinus W. R., Gilula L. A., Foulkes M. A., Kissane J. M., Askin F. B. Primary Ewing's sarcoma involving the bones of the head and neck. Cancer. 1987 Dec 1;60(11):2829–2840. doi: 10.1002/1097-0142(19871201)60:11<2829::aid-cncr2820601139>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  12. Watanabe H., Tsubokawa T., Katayama Y., Koyama S., Nakamura S. Primary Ewing's sarcoma of the temporal bone. Surg Neurol. 1992 Jan;37(1):54–58. doi: 10.1016/0090-3019(92)90067-w. [DOI] [PubMed] [Google Scholar]
  13. Zenke K., Hatakeyama T., Hashimoto H., Sakaki S., Manabe K. Primary Ewing's sarcoma of the occipital bone--case report. Neurol Med Chir (Tokyo) 1994 Apr;34(4):246–250. doi: 10.2176/nmc.34.246. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES